|
PHAR Pharming Group NV - ADR 1828316 |
| Income Statement |
|
Net Income
|
2025-12-31
|
$2,538,000.00 |
| Balance Sheet |
|
Current Assets
|
$299,469,000.00 |
|
Assets
|
$499,963,000.00 |
|
Current Liabilities
|
$115,791,000.00 |
|
Equity
|
$277,102,000.00 |
|
Shares Out
|
701680440.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$54,708,000.00 |
|
Investing Cash Flow
|
$26,252,000.00 |
| Market Analysis |
Market Cap
|
$8,385,081,258.00 |
|
Price
|
$12.19 |
|
BVPS
|
0.39 |
|
PB
|
30.64 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-10-01 09:31:27 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-10-26 10:00:21 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PHAR documents filed with the SEC.
PHAR Filings
Clear
